Clinical Trials in Asia Pacific Region An Introduction
Main Article Content
Abstract
The historical approach to conduct clinical trials and have served drug companies well for the past thirty years are typically located in US, UK Canada and Western European countries
The shrinking pools of treatment populations and increasingly intense competitive environment in the traditional North American and Western European markets have led sponsors to approach APAC Region to conduct cost effective quality research and secure timely enrollment of patients. This article focusses on five the most dynamic countries in APAC region.
Downloads
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Author(s) and co-author(s) jointly and severally represent and warrant that the Article is original with the author(s) and does not infringe any copyright or violate any other right of any third parties, and that the Article has not been published elsewhere. Author(s) agree to the terms that the IJRDO Journal will have the full right to remove the published article on any misconduct found in the published article.
References
Frost & Sullivan report: Global CRO market, 2016
Frost & Sullivan report: APAC Contract Research Organisation (CRO) Market, July 2015
Transforming Clinical Research in the United States: Challenges and Opportunities:
Workshop Summary, http://www.ncbi.nlm.nih.gov/books/NBK50888/
Rebecca Williams, PLoS, Terminated Trials in the ClinicalTrials.gov Results Database:
Evaluation of Availability of Primary Outcome Data and Reasons for Termination, 2015
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4444136/
Unger JM et al, Impact of the year 2000 Medicare policy change on older patient enrollment to cancer clinical trials. J Clin Oncol. 2006